Molecular Templates Inc MTEM:NASDAQ

Last Price$0.95Cboe Real-Time Last Sale as of 9:36AM ET 6/30/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.03(3.12%)
Bid (Size)$0.94 (100)
Ask (Size)$0.97 (167)
Day Low / High$0.95 - 0.95
Volume136.7 K
 

View Biotechnology IndustryPeer Comparison as of 06/30/2022

 

Molecular Templates Inc ( NASDAQ )

Price: $0.95
Change: -0.03 (3.12%)
Volume: 136.7 K
9:36AM ET 6/30/2022
 
 

Catalyst Biosciences Inc ( NASDAQ )

Price: $1.76
Change: +0.05 (2.92%)
Volume: 113.9 K
9:39AM ET 6/30/2022
 
 

Syros Pharmaceuticals Inc ( NASDAQ )

Price: $0.92
Change: -0.04 (4.09%)
Volume: 8.1 K
9:30AM ET 6/30/2022
 
 

Equillium Inc ( NASDAQ )

Price: $1.86
Change: +0.06 (3.33%)
Volume: 18.00
4:00PM ET 6/29/2022
 
 

Orgenesis Inc ( NASDAQ )

Price: $2.52
Change: 0.00 (0.00%)
Volume: 9.8 K
3:59PM ET 6/29/2022
 

Read more news Recent News

Insider Buy: Molecular Templates
5:27PM ET 6/21/2022 MT Newswires

Kevin M. Lalande, 10% Owner, Director, on June 13, 2022, executed a purchase for 222,000 shares in Molecular Templates (MTEM) for $198,380. Following the...

--BofA Securities Downgrades Molecular Templates to Underperform From Buy, Sets Price Target at $1.50
10:43AM ET 5/27/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Stifel Adjusts Molecular Templates' Price Target to $9 From $11, Reiterates Buy Rating
8:50AM ET 5/16/2022 MT Newswires

Molecular Templates (MTEM) has an average rating of buy and price targets ranging from $4.50 to $18, according to analysts polled by Capital IQ. (MT...

-- Earnings Flash (MTEM) MOLECULAR TEMPLATES Reports Q1 Revenue $8.5M
4:31PM ET 5/12/2022 MT Newswires

...

Company Profile

Business DescriptionMolecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean GariƩpy, and Leigh Revers in 2000 and is headquartered in Austin, TX. View company web site for more details
Address9301 Amberglen Boulevard
Austin, Texas 78729
Phone+1.512.869.1555
Number of Employees68
Director, Chief Executive & Scientific OfficerEric E. Poma
President & Chief Operating OfficerJason S. Kim
CFO, Senior Vice President & ControllerSean McLennan
Chief Medical OfficerRoger J. Waltzman

Company Highlights

Price Open$0.95
Previous Close$0.98
52 Week Range$0.76 - 8.29
Market Capitalization$53.3 M
Shares Outstanding56.3 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/11/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.38
Beta vs. S&P 500N/A
Revenue$13.3 M
Net Profit Margin-177.06%
Return on Equity-110.16%

Analyst Ratings as of 05/27/2022

Buy
5
Overweight
1
Hold
0
Underweight
1
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset